EZH2 and neoplasm: EZH2 inhibitors have shown that reverse gene silencing suppresses tumor growth and potentially reprograms the immune TME in an OS animal model and cell lines, by reducing the number of immunosuppressive TAMs and Tregs and restoring CXCL9 and CXCL10 expression.